Overexpression of cathepsin f, matrix metalloproteinases 11 and 12 in cervical cancer

BMC Cancer

Volumn 5, Issue , 2005, Pages

  Vazquez Ortiz, Guelaguetza ^a   Pina Sanchez, Patricia ^b   Vazquez, Karla ^a   Duenas, Alfonso ^b   Taja, Lucia ^b   Mendoza, Patricia ^a   Garcia, José A ^c   Salcedo, Mauricio ^a  

^a HOSPITAL DE ONCOLOGÍA   (Mexico)

^b Department of Immunology National Institute of Respiratory Diseases Ismael Cosío Villegas INCAN   (Mexico)

^c UNIVERSIDAD LA SALLE   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA1 INTEGRIN; ALPHA4 INTEGRIN; BETA INTEGRIN; CADHERIN; CATHEPSIN B; CATHEPSIN F; CATHEPSIN H; CATHEPSIN L; CATHEPSIN S; COLLAGENASE 3; DIPEPTIDYL PEPTIDASE I; ELASTASE; GELATINASE B; MACROPHAGE ELASTASE; STROMELYSIN 2; STROMELYSIN 3; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CONTROLLED STUDY; DENSITOMETRY; DNA MICROARRAY; DOWN REGULATION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; UPREGULATION; UTERINE CERVIX CANCER;

EID: 25444511458     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-5-68     Document Type: Article

References (44)

1. Mexican Ministry of Health: Registro Histopatolégico de Neoplasias Malignas, Compendio de mortalidad y morbilidad. Secretaría de Salud, México 1998.
2. Walboomers J, Jacobs M, Manos M, Bosch X, Kummer A, Shah K, Snijders P, Peto J, Meijer C, Muñoz N: Human Papilloma Virus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189:12-19.
3. Liotta LA, Kohn EC: The microenvironment of the tumor-host interface. Nature (Lond.) 2001, 411:375-379.
4. Egeblad M, Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nature Rev 2002, 2:163-176.
5. McCawley LJ, Matrisian LM: Matrix metalloproteinases: multifunctional contributors to tumor progression: a review. Mol Med Today 2000, 6:149-156.
6. Nagase H, Woessner JF Jr: Matrix metalloproteinases: a review. J Biol Chem 1999, 274:491-21.
7. McCawley LJ, Matrisian LM: Matrix metalloproteinases:they're not just for matrix anymore! Curr Opin Cell Biol 2001, 13:534-540.
8. Van Trappen PO, Ryan A, Carroll M, Lecoeur C, Goff L, Gyselman VG, Young BD, Lowe DG, Pepper MS, Shepherd JH, Jacobs IJ: A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer. Br J Cancer 2002, 87:537-544.
9. Shapiro SD, Kobayashi DK, Ley TJ: Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J Biol Chem 1993, 268:824-23.
10. Gronski TJ Jr, Martin RL, Kobayashi DK, Walsh BC, Holman MC, Huber M, Van Wart HE, Shapiro SD: Hydrolysis o a broad spectrum of extracellular matrix proteins by human macrophage metalloelastase. J Biol Chem 1997, 272:12189-12194.
11. Curci JA, Liao S, Huffman MD, Shapiro SD, Thompson RW: Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J Clin Invest 1999, 102:1900-1910.
12. Vaalamo M, Karjalainen-Lindsberg ML, Puolakkainen P, Kere J, Saarialho-Kere U: Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloe lastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations. Am J Pathol 1998, 152:1005-1014.
13. Kerkela E, Ala-Aho R, Jeskanen L, Rechardt O, Grenman R, Shapiro SD, Kahari VM, Saarialho-Kere U: Expression of human macrophage metalloelastase (MMP-12) by tumor cells in skin cancer. J Invest Dermatol 2000, 114:1113-1119.
14. Kerkela E, Ala-aho R, Klemi P, Grenman S, Shapiro SD, Kahari VM, Saarialho-Kere U: Metalloelastase (MMP-12) expression by tumour cells in squamous cell carcinoma of the vulva correlates with invasiveness, while that by macrophages predicts better outcome. J Pathol 2002, 198:258-269.
15. Noel A, Boulay A, Kebers F, Kannan R, Hajitou A, Calberg-Bacq CM, Basset P, Rio MC, Foidart JM: Demonstration in vivo that stromelysin-3 functions through its proteolytic activity. Oncogene 2000, 19:1605-1612.
16. Boulay A, Masson R, Chenard MP, El Fahime M, Cassard L, Bellocq JP, Sautes-Fridman C, Basset P, Rio MC: High cancer cell death in syngeneic tumors developed in host mice deficient for the stromelysin-3 matrix metalloproteinase. Cancer Res 2001, 61:2189-2193.
17. Yamashita K, Tanaka Y, Mimori K, Inoue H, Mori M: Differential expression of MMP and uPA systems and prognostic relevance of their expression in esophageal squamous cell carcinoma. Int J Cancer 2004, 110:201-207.
18. Soni S, Mathur M, Shukla NK, Deo SV, Ralhan R: Stromelysin-3 expression is an early event in human oral tumorigenesis. Int J Cancer 2003, 107:309-316.
19. Wasenius VM, Hemmer S, Kettunen E, Knuutila S, Franssila K, Joensuu H: Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study. Clin Cancer Res 2003, 9:68-75.
20. Wlodarczyk J, Stolte M, Mueller J: E-cadherin, beta-catenin and stromelysin-3 expression in de novo carcinoma of the colorectum. Pol J Pathol 2001, 52:119-124.
21. Thewes M, Worret WI, Engst R, Ring J: Stromelysin-3 (ST-3): immunohistochemical characterization of the matrix metalloproteinase (MMP)-11 in benign and malignant skin tumours and other skin disorders. Clin Exp Dermatol 1999, 24:122-126.
22. Mueller J, Brebeck B, Schmalfeldt B, Kuhn W, Graeff H, Hofler H: tromelysin-3 expression in invasive ovarian carcinomas and tumours of low malignant potential. Virchows Arch 2000, 437:618-624.
23. Basset P, Bellocq JP, Lefebre O, Noel A, Chenard MP, Wolf C, Anglard P, Rio MC: Stromelysin-3: a paradigm for stromaderived factors implicated in carcinoma progression. Crit Rev Oncol Hematol 1997, 26:43-53.
24. Wex T, Levy B, Wex H, Bromme D: Human cathepsins W and F form a new subgroup of cathepsins that is evolutionary separated from the cathepsin B- and L-like cysteine proteases. Adv Exp Med Biol 2000, 477:271-280.
25. Santamaria I, Velasco G, Pendas AM, Paz A, Lopez-Otin C: Molecular cloning and structural and functional characterization of human cathepsin F, a new cysteine proteinase of the papain family with a long propeptide domain. J Biol Chem 1999, 274:13800-13809.
26. Cross SS, Hamdy FC, Deloulme JC, Rehman I: Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. Histopathology 2005, 46:256-269.
27. Caceres-Cortes JR, Alvarado-Moreno JA, Waga K, Rangel-Corona R, Monroy-Garcia A, Rocha-Zavaleta L, Urdiales-Ramos J, Weiss-Steider B, Haman A, Hugo P, Brousseau R, Hoang T: Implication of tyrosine kinase receptor and steel factor in cell density-dependent growth in cervical cancers and leukemias. Cancer Res 2001, 61:6281-6289.
28. Hidalgo A,Piña P, Guerrero G, Salcedo M: A simple method for the construction of small format tissue array. J Clin Pathol 2003, 56:144-146.
29. Smyth GK: Limma: linear models for microarray data. In Bioinformatics and Computational Biology Solutions using R and Bioconductor, Chapter 23 Edited by: Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W. Springer, New York in press.
30. Smyth GK: Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Statistical Applications in Genetics and Molecular Biology Smyth, G. K 2004, 3:33.
31. Hoon N, Hong K, Hui S, Kang S, Young K, Ho S: MMP expression profiling in recurred stage IB lung cancer. Oncogene 2004, 23:845-851.
32. Boulay A, Masson R, Chenard MP, El Fahime M, Cassard L, Bellocq JP, Sautes-Fridman C, Basset P, Rio MC: High cancer cell death in syngeneic tumors developed in host mice deficient for the stromelysin-3 matrix metalloproteinase. Cancer Res 2001, 61:2189-2193.
33. Basset P, Bellocq J, Wolf C, Stoll I, Hutin P, Limacher J, Podhajcer O, Chernard M, Rio M, Chambon P: A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 1990, 348:699-703.
34. Rouyer N, Wolf C, Chenard MP, Rio M, Chabon P, Belloq J, Basset P: Stromelysin-3 gene expression in human cancer: an overview. Invasion Metastasis 1994, 95:41269-41275.
35. Basset P, Bellocq J, Lefebvre O, Noel A, Chenard M, Wolf C, Anglard P, Rio m: Stromelysin 3: a paradigm for stroma derived factors implicated in carcinoma progression. Crit Rev Oncol Hematol 1997, 26:43-53.
36. Shipley M, Wesselchmidt R, Kobashi K, Ley T, Shapiro S: Metalloelastase is required for macrophage mediated proteolysis and matrix invasion in mice. Proc Natl Acd Sci USA 1996, 93:3942-3946.
37. Impola U, Uitto VJ, Hietanen J, Hakkinen K, Zhang L, Larjava H, Isaka K, Saarialho-Kere U: V Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer. J Pathol 2004, 202:14-22.
38. Chapman H, Riese RJ, Guo-Ping S: Emerging roles for cysteine proteases in human biology. Ann Rev Physiol 1997, 59:63-88.
39. Van Trappen P, Ryan A, Carroll M, Lecoeur C, Goff L, Gyselman V, Young BD, Lowe DG: A model of co-expression pattern analysis of genes implicated in angiogenesis and tumor cell invasion in cervical cancer. Brit J Can 2002, 87:537-544.
40. Arguello-Ramirez J, Perez-Cardenas E, Delgado-Chavez R, Solorza-Luna G, Villa-Trevino S, Arenas-Huertero F: Matrix metalloproteinases-2, -3, and -9 secreted by explants of benign and malignant lesions of the uterine cervix. Int J Gynecol Cancer 2004, 14:333-40.
41. Kato Y, Yamashita T, Ishikawa M: Relationship between expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 and invasion ability of cervical cancer cells. Oncol Rep 2002, 9:565-9.
42. Davidson B, Goldberg I, Kopolovic J, Lerner-Geva L, Gotlieb WH, Weis B, Ben-Baruch G, Reich R: Expression of matrix metalloproteinase-9 in squamous cell carcinoma of the uterine cervix-clinicopathologic study using immunohistochemistry and mRNA in situ hybridization. Gynecol Oncol 1999, 72:380-6.
43. Davidson B, Goldberg I, Liokumovich P, Kopolovic J, Gotlieb WH, Lerner-Geva L, Reder I, Ben-Baruch G, Reich R: Expression of metalloproteinases and their inhibitors in adenocarcinoma of the uterine cervix. Int J Gynecol Pathol 1998, 17:295-301.
44. Veli-Matti Wasenius, Hemmer S, Kettunen E, Sakari Knuutila, Fanssila K, Heikki J: Hepatocyte Growth Factor Receptor, Matrix Metalloproteinase-11, Tissue Inhibitor of Metalloproteinase-1, and Fibronectin Are Up-Regulated in Papillary Thyroid Carcinoma: A cDNA and Tissue Microarray Study. Clin Can Res 2003, 9:68-75.